PrescriptSure, Inc.
StreetZero Signal 56
About PrescriptSure, Inc.
PrescriptSure helps outpatient practices see coverage, prior authorization requirements, and covered alternatives before the prescription is sent. The tool aims to reduce rejected prescriptions, follow-up calls, and staff workload by surfacing information earlier in the workflow. It is currently inviting practices to an early waitlist and shaping initial EHR integrations.
LATEST FUNDINGPrivate Placement
$250K
Announced 2026-09-22
TOTAL RAISED$250,000
IN THE NEWS
- 🔗 Annual Impact Report 2025
- 🔗 PrescriptSure — See coverage before the prescription is sent
- 🔗 Prescryptive Health - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Exclusive: Surescripts Hires TripleTree to Find a Buyer - Business Insider
- 🔗 Prescryptive Health Closes $26 Million Series A Financing - Prescryptive Health
EMPLOYEES—
FOUNDED—
HQIrving, TX, United States
Industry
Other Technology
Tags
HealthcarePrescriptionB2BPrior Authorization
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- PrescriptSure targets coverage visibility and prior authorization requirements before prescriptions are sent.
- The platform is positioned for outpatient practices and is currently in an early waitlist phase.
- The $250k private placement occurred in Irving, TX with undisclosed investors.
- Focus is on reducing administrative burden from rejected prescriptions and pharmacy callbacks.
Ask StreetZero about PrescriptSure, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account